Sunvij Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
- Paid Up Capital ₹ 1.50 Cr
- Company Age 30 Year, 5 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.11 Cr
- Revenue Growth 11.44%
- Profit Growth 7.92%
- Ebitda -0.57%
- Net Worth 29.49%
- Total Assets 10.81%
About Sunvij Drugs
Sunvij Drugs Private Limited (SDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 February 1995 and has a history of 30 years. Its registered office is in Vadodara, Gujarat, India.
The Corporate was formerly known as Sunvij Drugs Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company has closed loans amounting to ₹7.11 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Vaghasia and Shirishkumar Vaghasia serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232GJ1995PTC077943
-
Company No.
077943
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Feb 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Sunvij Drugs Private Limited offer?
Sunvij Drugs Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Brain & Nervous System Drugs, Psychotherapeutic Agents, Digestive System Drugs & Medicines, Antiemetic, Healthcare Products & Aids, Health Drinks, Pharmaceutical Capsules.
Who are the key members and board of directors at Sunvij Drugs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Vaghasia
|
Managing Director | 13-Mar-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shirishkumar Vaghasia
|
Director | 15-Oct-2020 | Current |
Financial Performance of Sunvij Drugs.
Sunvij Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.44% increase. The company also saw a slight improvement in profitability, with a 7.92% increase in profit. The company's net worth Soared by an impressive increase of 29.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunvij Drugs?
In 2023, Sunvij Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Scorro Pack Private LimitedMukesh Vaghasia is a mutual person
Charges (Loans)
₹0
₹7.11 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 2.81 Cr
- Oriental Bank Of Commerce : 1.63 Cr
- Capital First Limited : 1.50 Cr
- Sidbi : 1.00 Cr
- Others : 0.15 Cr
- Others : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jun 2021 | Sidbi | ₹1.00 Cr | Satisfied |
| 01 Jan 2021 | Hdfc Bank Limited | ₹1.20 Cr | Satisfied |
| 30 Jun 2020 | Others | ₹1.50 M | Satisfied |
| 23 Dec 2016 | Hdfc Bank Limited | ₹1.11 Cr | Satisfied |
| 09 Dec 2016 | Hdfc Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Sunvij Drugs?
Sunvij Drugs has a workforce of 23 employees as of Jun 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunvij Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunvij Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
